Dechert Advises Tyber Medical on Acquisition by Montagu and Subsequent Merger with Intech and Resolve Surgical Technologies

Dechert advised Tyber Medical on its definitive agreement to be acquired by Montagu, a leading mid-market private equity firm.

In its effort to create a world-leading medical devices supplier, Montagu will support the merger of Tyber Medical, Intech and Resolve Surgical Technologies. The merger, subject to customary regulatory approvals and closing conditions, will combine Tyber Medical with Montagu’s existing investments in Resolve, a leading provider of contract device design, manufacturing and lifecycle management services, as well as in Intech, a leader in the co-development and manufacturing of complex orthopaedic surgical devices.

The combined entity will offer a unique mix of proprietary market-cleared technologies as well as development and manufacturing scale, enabling OEM customers to achieve unmatched speed to market and enhance supply chain resilience and effectiveness. Upon merging, the platform will be a leading contract supplier of systems for Spine, Trauma, Extremities, Sports Medicine and Enabling Technologies with plans to expand into additional markets. The merger will support accelerated innovation and help improve standards of care for patients globally.

Tyber Medical is a leading orthopaedic device manufacturer providing rapid access to FDA-cleared and CE-marked, private label, portfolio-enhancing regulatory-approved orthopaedic implants for the spinal, extremity and trauma markets.

The Dechert team that advised Tyber Medical was led by corporate partners Jonathan R. Stott and Stephanie L. Haas and included corporate partner Ermine Bolot and associates Rachel Davies, William J. Roberts and Anaïs Fritzinger; employee benefits partner Howard M. Klein and associate Taylor Knowles; global tax partner Kevin Zaragoza and associate Abigail Hopper; and antitrust partner James A. Fishkin and counsel Beverly J. Ang.

About Dechert

Dechert is a global law firm that advises asset managers, financial institutions and corporations on issues critical to managing their business and their capital – from high-stakes litigation to complex transactions and regulatory matters. We answer questions that seem unsolvable, develop deal structures that are new to the market and protect clients' rights in extreme situations. Our nearly 1,000 lawyers across 19 offices globally focus on the financial services, private equity, private credit, real estate, life sciences and technology sectors.